The role of the cylooxygenase pathway in nociception and pain.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Seminars in Cell and Developmental Biology

• Publication date

  2006-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.SEMCDB.2006.09.001PMID 17071117
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rengyolone inhibits inducible nitric oxide synthase expression and nitric oxide production by down-regulation of NF-kappaB and p38 MAP kinase activity in LPS-stimulated RAW 264.7 cells.

  2006cited by this paper
• COX-2 inhibitors and the heart: are all coxibs the same?

  2006cited by this paper
• Different COX-independent effects of the COX-2 inhibitors etoricoxib and lumiracoxib.

  2006cited by this paper
• Heme catalyzes tyrosine 385 nitration and inactivation of prostaglandin H2 synthase-1 by peroxynitrite Published, JLR Papers in Press, February 9, 2006.

  2006cited by this paper
• Patients Exposed to Rofecoxib and Celecoxib Have Different Odds of Nonfatal Myocardial Infarction

  2005cited by this paper
• Human cyclo-oxygenase-1 and an alternative splice variant: contrasts in expression of mRNA, protein and catalytic activities.

  2005cited by this paper
• Tumor necrosis factor α and interleukin‐1β stimulate the expression of cyclooxygenase II but do not alter prostaglandin E2 receptor mRNA levels in cultured dorsal root ganglia cells

  2005cited by this paper
• Spinal inflammatory hyperalgesia is mediated by prostaglandin E receptors of the EP2 subtype.

  2005cited by this paper
• Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study.

  2005cited by this paper
• Is COX-2 a perpetrator or a protector? Selective COX-2 inhibitors remain controversial

  2005cited by this paper
• Prostaglandin E2 induces cyclooxygenase-2 expression in human non-pigmented ciliary epithelial cells through activation of p38 and p42/44 mitogen-activated protein kinases.

  2005cited by this paper
• Cloning, Expression, and Functional Characterization of Human Cyclooxygenase-1 Splicing Variants: Evidence for Intron 1 Retention

  2005cited by this paper
• Sinusoidal endothelial COX-1-derived prostanoids modulate the hepatic vascular tone of cirrhotic rat livers.

  2005cited by this paper
• Role of p38 in nitric oxide synthase and cyclooxygenase expression, and nitric oxide and PGE2 synthesis in human gingival fibroblasts stimulated with lipopolysaccharides.

  2005cited by this paper
• Cyclooxygenases, Thromboxane, and Atherosclerosis: Plaque Destabilization by Cyclooxygenase-2 Inhibition Combined With Thromboxane Receptor Antagonism

  2005cited by this paper
• Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial.

  2005cited by this paper
• Regulation of cyclooxygenase catalysis by hydroperoxides.

  2005cited by this paper
• Effects of estrogen with and without progestin on urinary incontinence

  2005cited by this paper
• The Cyclooxygenase-2 Inhibitor GW406381X [2-(4-Ethoxyphenyl)-3-[4-(methylsulfonyl)phenyl]-pyrazolo[1,5-b]pyridazine] Is Effective in Animal Models of Neuropathic Pain and Central Sensitization

  2005cited by this paper
• Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis

  2005cited by this paper
• Celecoxib Decreases Endothelial Tissue Factor Expression Through Inhibition of c-Jun Terminal NH2 Kinase Phosphorylation

  2005cited by this paper
• Transcriptional Control of COX-2 via C/EBP&bgr;

  2005cited by this paper
• Prostaglandin E2 potentiates a TTX‐resistant sodium current in rat capsaicin‐sensitive vagal pulmonary sensory neurones

  2005cited by this paper
• GlyR α3: An Essential Target for Spinal PGE2-Mediated Inflammatory Pain Sensitization

  2004cited by this paper
• Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial.

  2004cited by this paper
• The Effects of Modifying In Vivo Cytochrome P450 3A (CYP3A) Activity on Etoricoxib Pharmacokinetics and of Etoricoxib Administration on CYP3A Activity

  2004cited by this paper
• Increase of cyclooxygenase-2 expression by interleukin 15 in rheumatoid synoviocytes.

  2004cited by this paper
• Vioxx: an unequal partnership between safety and efficacy.

  2004cited by this paper
• Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial.

  2004cited by this paper
• The 2.0 A resolution crystal structure of prostaglandin H2 synthase-1: structural insights into an unusual peroxidase.

  2004cited by this paper
• Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition

  2004cited by this paper
• COX-2-Derived Prostacyclin Confers Atheroprotection on Female Mice

  2004cited by this paper
• Sulfone COX-2 inhibitors increase susceptibility of human LDL and plasma to oxidative modification: comparison to sulfonamide COX-2 inhibitors and NSAIDs.

  2004cited by this paper
• Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic

  2004cited by this paper
• Strong inhibition of TNF-α production and inhibition of IL-8 and COX-2 mRNA expression in monocyte-derived macrophages by RWJ 67657, a p38 mitogen-activated protein kinase (MAPK) inhibitor

  2004cited by this paper
• Clinical pharmacology of novel selective COX-2 inhibitors.

  2004cited by this paper
• The structure of mammalian cyclooxygenases.

  2003cited by this paper
• Spinal nerve injury activates prostaglandin synthesis in the spinal cord that contributes to early maintenance of tactile allodynia

  2003cited by this paper
• The prostaglandin E2 receptor-1 (EP-1) mediates acid-induced visceral pain hypersensitivity in humans.

  2003cited by this paper
• A Novel Mechanism of Cyclooxygenase-2 Inhibition Involving Interactions with Ser-530 and Tyr-385*

  2003cited by this paper
• Cyclooxygenase-2 biology.

  2003cited by this paper
• Effect of selective cyclooxygenase 2 inhibitors and naproxen on short-term risk of acute myocardial infarction in the elderly.

  2003cited by this paper
• The development of COX2 inhibitors

  2003cited by this paper
• Cyclooxygenase‐1 in the spinal cord plays an important role in postoperative pain

  2003cited by this paper
• Mechanism of free radical oxygenation of polyunsaturated fatty acids by cyclooxygenases.

  2003cited by this paper
• COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease.

  2002cited by this paper
• The gastrointestinal effects of nonselective NSAIDs and COX-2-selective inhibitors.

  2002cited by this paper
• Effects of a Novel Selective Agonist for Prostaglandin Receptor Subtype EP4 on Hyperalgesia and Inflammation in Monoarthritic Model

  2002cited by this paper
• Function of prostanoid receptors: studies on knockout mice.

  2002cited by this paper
• The risk of cardiovascular thrombotic events with selective cyclooxygenase-2 inhibitors.

  2002cited by this paper
• Interleukin-1β-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity

  2001cited by this paper
• Overexpression of Functionally Coupled Cyclooxygenase-2 and Prostaglandin E Synthase in Symptomatic Atherosclerotic Plaques as a Basis of Prostaglandin E2-Dependent Plaque Instability

  2001cited by this paper
• Anti-inflammatory drugs: new multitarget compounds to face an old problem. The dual inhibition concept.

  2001cited by this paper
• Structural analysis of NSAID binding by prostaglandin H2 synthase: time-dependent and time-independent inhibitors elicit identical enzyme conformations.

  2001cited by this paper
• Prostaglandins and leukotrienes: advances in eicosanoid biology.

  2001cited by this paper
• Participation of cyclooxygenases in cutaneous thermal nociception under non-inflamed and inflamed conditions

  2001cited by this paper
• Peroxidase Self-inactivation in Prostaglandin H Synthase-1 Pretreated with Cyclooxygenase Inhibitors or Substituted with Mangano Protoporphyrin IX*

  2001cited by this paper
• Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation.

  2001cited by this paper
• Cyclooxygenase‐1 and cyclooxygenase‐2 selectivity of non‐steroidal anti‐inflammatory drugs: investigation using human peripheral monocytes

  2001cited by this paper
• Characterization of EP receptor subtypes responsible for prostaglandin E2‐induced pain responses by use of EP1 and EP3 receptor knockout mice

  2001cited by this paper
• Prostaglandin Endoperoxide H Synthase-1

  2001cited by this paper
• Dose Proportionality of Oral Etoricoxib, a Highly Selective Cyclooxygenase‐2 Inhibitor, in Healthy Volunteers

  2001cited by this paper
• The coxibs, selective inhibitors of cyclooxygenase-2.

  2001cited by this paper
• Effects of selective COX‐1 and ‐2 inhibition on formalin‐evoked nociceptive behaviour and prostaglandin E2 release in the spinal cord

  2001cited by this paper
• The productive conformation of arachidonic acid bound to prostaglandin synthase.

  2000cited by this paper
• Cyclooxygenase‐1 is a marker for a subpopulation of putative nociceptive neurons in rat dorsal root ganglia

  2000cited by this paper
• Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis.

  2000cited by this paper
• Clinical Pharmacokinetics and Pharmacodynamics of Celecoxib

  2000cited by this paper
• Endothelial Dysfunction, Hemodynamic Forces, and Atherogenesis a

  2000cited by this paper
• Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group.

  2000cited by this paper
• Cyclooxygenases: structural, cellular, and molecular biology.

  2000cited by this paper
• Upregulation of cyclooxygenase-1 and the PGE2 receptor EP2 in rat and human mesangioproliferative glomerulonephritis

  2000cited by this paper
• Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.

  2000cited by this paper
• Structural insights into the stereochemistry of the cyclooxygenase reaction

  2000cited by this paper
• The Membrane Binding Domains of Prostaglandin Endoperoxide H Synthases 1 and 2

  1999cited by this paper
• Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions.

  1999cited by this paper
• Kinetic basis for selective inhibition of cyclo-oxygenases.

  1999cited by this paper
• Tetrodotoxin-resistant Na+ currents and inflammatory hyperalgesia.

  1999cited by this paper
• Prostanoid receptors: structures, properties, and functions.

  1999cited by this paper
• Dexamethasone prevents the induction of COX-2 mRNA and prostaglandins in the lumbar spinal cord following intraplantar FCA in parallel with inhibition of oedema.

  1998cited by this paper
• A tetrodotoxin-resistant sodium current mediates inflammatory pain in the rat.

  1998cited by this paper
• Cyclooxygenases 1 and 2.

  1998cited by this paper
• Prostanoids synthesized by cyclo‐oxygenase isoforms in rat spinal cord and their contribution to the development of neuronal hyperexcitability

  1997cited by this paper
• Altered pain perception and inflammatory response in mice lacking prostacyclin receptor

  1997cited by this paper
• PGE2 modulates the tetrodotoxin‐resistant sodium current in neonatal rat dorsal root ganglion neurones via the cyclic AMP‐protein kinase A cascade.

  1996cited by this paper
• Role of a Ca(2+)-dependent slow afterhyperpolarization in prostaglandin E2-induced sensitization of cultured rat sensory neurons.

  1996cited by this paper
• Prostaglandin Endoperoxide H Synthases (Cyclooxygenases)-1 and −2*

  1996cited by this paper
• Photolabeling of Prostaglandin Endoperoxide H Synthase-1 with 3-Trifluoro-3-(m-Iiodophenyl)diazirine as a Probe of Membrane Association and the Cyclooxygenase Active Site (*)

  1996cited by this paper
• Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents

  1996cited by this paper
• Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation.

  1994cited by this paper
• The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1

  1994cited by this paper
• Acetylation of human prostaglandin endoperoxide synthase-2 (cyclooxygenase-2) by aspirin.

  1994cited by this paper
• Selective inhibition of cyclooxygenase 2.

  1994cited by this paper
• Selective inhibition of NS‐398 on prostanoid production in inflamed tissue in rat carrageenan‐air‐pouch inflammation

  1993cited by this paper
• The aspirin and heme-binding sites of ovine and murine prostaglandin endoperoxide synthases.

  1990cited by this paper
• Anti-inflammatory and safety profile of DuP 697, a novel orally effective prostaglandin synthesis inhibitor.

  1990cited by this paper

• Isolation, structural characterization and molecular docking of β-sitosterol from Trewia polycarpa root bark: a potential source of bioactive compounds

  2025influential citation
• Association of inflammation, oxidative stress, and deteriorated cognitive functions in patients after cardiac surgery

  2024cites this paper
• GC–MS analysis, molecular docking, and pharmacokinetic studies of Multidentia crassa extracts’ compounds for analgesic and anti-inflammatory activities in dentistry

  2024cites this paper
• Mechanically Derived Tissue Stromal Vascular Fraction Acts Anti-inflammatory on TNF Alpha-Stimulated Chondrocytes In Vitro

  2022cites this paper
• Repurposing of digoxin in pain and inflammation: An evidence‐based study

  2022influential citation
• Neuropharmacological basis for multimodal analgesia in chronic pain

  2021cites this paper
• Antinociceptive and Anti-Inflammatory Effects of Recombinant Crotamine in Mouse Models of Pain

  2021cites this paper
• Melatonin antagonizes lipopolysaccharide-induced pulpal fibroblast responses

  2020cites this paper
• Quantification of the influence of drugs on zebrafish larvae swimming kinematics and energetics

  2020cites this paper
• Quantification of computational fluid dynamics simulation assists the evaluation of Gypenoside protection in a zebrafish pain model.

  2020cites this paper
• Efficacy and Safety of COX-2 Inhibitor Parecoxib for Rigid Cystoscopy-related Pain Management in Male Patients: A Prospective, Randomized and Controlled Study

  2019cites this paper
• Releasing Behavior of Lipopolysaccharide from Gelatin Modulates Inflammation, Cellular Senescence, and Bone Formation in Critical-Sized Bone Defects in Rat Calvaria

  2019cites this paper
• Electrochemical behaviour of dipyrone (metamizole) and others pyrazolones

  2018cites this paper
• Pain Management in Abdominal Wall Reconstruction

  2017cites this paper
• Oxidative Stress and Opioids

  2016cites this paper
• Copy number variation in ALOX5 and PTGER1 is associated with NSAIDs-induced urticaria and/or angioedema

  2016cites this paper
• Self-assembling ultrashort NSAID-peptide nanosponges: multifunctional antimicrobial and anti-inflammatory materials

  2016cites this paper
• Modeling Nociception in Zebrafish: A Way Forward for Unbiased Analgesic Discovery

  2015cites this paper
• Synergistic antinociceptive effect and gastric safety of the combination of docosahexaenoic acid and indomethacin in rats.

  2014cites this paper
• Ból neuropatyczny — patomechanizm

  2014cites this paper
• Avaliação das atividades antimicrobiana, aderência, antioxidante, anti-inflamatória e antinociceptiva de Anadenanthera macrocarpa (benth) brenan

  2013cites this paper
• Cyclic Systems Distribution Along Similarity Measures: Insights for an Application to Activity Landscape Modeling

  2013cites this paper
• p300 exerts an epigenetic role in chronic neuropathic pain through its acetyltransferase activity in rats following chronic constriction injury (CCI)

  2012cites this paper
• CASE Plots for the Chemotype‐Based Activity and Selectivity Analysis: A CASE Study of Cyclooxygenase Inhibitors

  2012cites this paper
• Mitragynine inhibits the COX-2 mRNA expression and prostaglandin E₂ production induced by lipopolysaccharide in RAW264.7 macrophage cells.

  2011cites this paper
• Epoxygenated fatty acids and soluble epoxide hydrolase inhibition: novel mediators of pain reduction.

  2011cites this paper
• Intraoperative infusion of S(+)-ketamine enhances post-thoracotomy pain control compared with perioperative parecoxib when used in conjunction with thoracic paravertebral ropivacaine infusion.

  2011cites this paper
• Activation of the signaling cascade in response to T lymphocyte receptor stimulation and prostanoids in a case of cutaneous lupus

  2011cites this paper
• Hydroxamic Acids: Chemistry, Bioactivity, and Solutionand Solid‐Phase Synthesis

  2010cites this paper
• Progress in COX-2 inhibitors: a journey so far.

  2010cites this paper
• Knockdown of L Calcium Channel Subtypes: Differential Effects in Neuropathic Pain

  2010cites this paper
• The role of translational regulation in ultraviolet light‐induced cyclooxygenase‐2 expression

  2009cites this paper
• Antinociceptive and anti-inflammatory effects of the essential oil of Eugenia candolleana DC., Myrtaceae, on mice

  2009cites this paper
• Cancer Pain: Nociception: basic principles

  2009cites this paper
• Enhanced bladder capacity and reduced prostaglandin E2-mediated bladder hyperactivity in EP3 receptor knockout mice.

  2008cites this paper
• Age-related difference in nociceptive behavior between SAMP6 and SAMR1 strains.

  2008cites this paper
• mediated bladder hyperactivity in EP3 receptor knock-out mice

  2008cites this paper
• Gene Expression Profile of Dorsal Root Ganglion in a Lumbar Radiculopathy Model

  2008cites this paper
• Mechanisms of pain in nonmalignant disease

  2008cites this paper
• Prospective, Double-Blinded, Randomized, Placebo-Controlled Comparison of Local Anesthetic and Nonsteroidal Anti-Inflammatory Drugs for Postoperative Pain Management after Laparoscopic Surgery

  2007cites this paper
• INVESTIGATION OF THE BIOTRANSFORMATION OF 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE BY PROSTAGLANDIN H SYNTHASE AND CYTOCHROME P450 2F

  2007cites this paper